top of page

Our Portfolio

[yeda]Logo 2.png

A personalized medicine startup helping users prevent sudden glycemic spikes and manage metabolic conditions such as type 2 diabetes, overweight, and obesity. By combining artificial intelligence with gut microbiome insights, Yeda predicts individual glycemic responses to each meal. While inspired by global success stories, Yeda is purpose-built for the unique needs of the LATAM population, starting in Brazil.

In Hand Mobile Mockup.jpg

Our first product is a mobile app that integrates food logging, continuous glucose monitoring, and bioimpedance analysis to provide real-time, personalized dietary recommendations. This empowers users to make practical, daily adjustments that stabilize glucose levels, improve body composition, and enhance overall health. We are also building a proprietary, region-specific dataset and training our own predictive engine—an asset no international player can offer in LATAM.

el-hospital-israelita-albert-einstein-en-Y6YHCO4FVZBPTOUHPOV66VY4G4.avif

Yeda has partnered with Hospital Albert Einstein for validation and distribution, positioning us to lead the precision health movement across the region. We operate under a B2B SaaS model, offering private clinics and fitness chains scalable tools for metabolic health management. As GLP-1 therapies like Ozempic reshape the landscape, Yeda is uniquely positioned to complement this trend. This is how we aim to lead LATAM into the next era of AI-powered, precision healthcare.

Fernando Slamovitz - CEO_edited.png

Fernando Slamovitz

CEO

Lorenza Vecino Schandy - CTO_edited.png

Lorenza Vecino Schandy

CTO

Juan Elenter - CPO_edited_edited.png

Juan Elenter

CPO

bottom of page